Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 Myoblasts

ABSTRACT Ligand activation of the fibroblast growth factor receptor (FGFR) represses myogenesis and promotes activation of extracellular signal-regulated kinases 1 and 2 (Erks). The precise mechanism through which the FGFR transmits both of these signals in myoblasts remains unclear. The SH2 domain-containing protein tyrosine phosphatase, SHP-2, has been shown to participate in the regulation of FGFR signaling. However, no role for SHP-2 in FGFR myogenic signaling is known. In this study, we show that stimulation of C2C12 myoblasts with FGF-2 induces SHP-2 complex formation with tyrosyl-phosphorylated FGFR substrate 2α (FRS-2α). Both the catalytic activity and, to a much lesser extent, the Grb2 binding-tyrosyl phosphorylation sites of SHP-2 are required for maximal FGF-2-induced Erk activity and Elk-1 transactivation. When overexpressed in C2C12 myoblasts, wild-type SHP-2, but not a catalytically inactive SHP-2 mutant, potentiates the suppressive effects of FGF-2 on muscle-specific gene expression. In addition, expression of a constitutively active mutant of SHP-2 is sufficient to prevent myogenesis. The constitutively active mutant of SHP-2 induces hyper-tyrosyl phosphorylation of FRS-2α but fails to stimulate or potentiate either FGF-2-induced Erk activation or Elk-1 transactivation. These data suggest that in myoblasts, SHP-2 represses myogenesis via a pathway that is independent of the Erks. We propose that SHP-2 plays a pivotal role in FGFR signaling in myoblasts via both Erk-dependent and Erk-independent pathways.

[1]  B. Neel,et al.  Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Land,et al.  A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. , 1990, Nucleic acids research.

[3]  B. Neel,et al.  Role of phosphatases in lymphocyte activation. , 1997, Current opinion in immunology.

[4]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Jones,et al.  ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion , 2001, Journal of cellular physiology.

[6]  M. Welham,et al.  Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3'-kinase. , 1994, The Journal of biological chemistry.

[7]  M. R. Calera,et al.  Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways , 1996, Molecular and cellular biology.

[8]  Harold Weintraub,et al.  The MyoD family and myogenesis: Redundancy, networks, and thresholds , 1993, Cell.

[9]  B. Neel,et al.  Tyrosyl phosphorylation and growth factor receptor association of the human corkscrew homologue, SH-PTP2. , 1993, The Journal of biological chemistry.

[10]  B. Neel,et al.  Activated Mutants of SHP-2 Preferentially Induce Elongation of Xenopus Animal Caps , 2000, Molecular and Cellular Biology.

[11]  S. Tapscott,et al.  Mitogen-activated Protein Kinase Pathway Is Involved in the Differentiation of Muscle Cells* , 1998, The Journal of Biological Chemistry.

[12]  Zhenguo Wu,et al.  p38 and Extracellular Signal-Regulated Kinases Regulate the Myogenic Program at Multiple Steps , 2000, Molecular and Cellular Biology.

[13]  B. Olwin,et al.  Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms , 1996, The Journal of cell biology.

[14]  Y. Fedorov,et al.  Oncogenic Ras-Induced Proliferation Requires Autocrine Fibroblast Growth Factor 2 Signaling in Skeletal Muscle Cells , 2001, The Journal of cell biology.

[15]  N. Tonks,et al.  Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. , 1997, Science.

[16]  E. Olson,et al.  MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. , 1999, Current opinion in cell biology.

[17]  M. Primig,et al.  Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. , 2000, Molecular biology of the cell.

[18]  G. Feng,et al.  The protein tyrosine phosphatase Shp-2 regulates RhoA activity , 2000, Current Biology.

[19]  B. Neel,et al.  Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression , 1996, Molecular and cellular biology.

[20]  Z. Zhao,et al.  A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Florini,et al.  The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.

[22]  J. Dimario,et al.  Regulation of avian fibroblast growth factor receptor 1 (FGFR-1) gene expression during skeletal muscle differentiation. , 1999, Gene.

[23]  A. Sharrocks,et al.  Differential targeting of MAP kinases to the ETS‐domain transcription factor Elk‐1 , 1998, The EMBO journal.

[24]  G. Spizz,et al.  Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation. , 1986, The Journal of biological chemistry.

[25]  A. Bennett,et al.  SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis. , 2001, Journal of cell science.

[26]  H. Broxmeyer,et al.  Involvement of SH2-containing Phosphotyrosine Phosphatase Syp in Erythropoietin Receptor Signal Transduction Pathways (*) , 1995, The Journal of Biological Chemistry.

[27]  P. Houghton,et al.  The molecular basis of skeletal muscle differentiation. , 1994, Seminars in diagnostic pathology.

[28]  L. Glaser,et al.  Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle , 1985, The Journal of cell biology.

[29]  S. Shoelson,et al.  Crystal Structure of the Tyrosine Phosphatase SHP-2 , 1998, Cell.

[30]  P. Maher,et al.  p38 Mitogen-activated Protein Kinase Activation Is Required for Fibroblast Growth Factor-2-stimulated Cell Proliferation but Not Differentiation* , 1999, The Journal of Biological Chemistry.

[31]  E. Krebs,et al.  Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Bar-Sagi,et al.  A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathway , 1997, Cell.

[33]  M. White,et al.  A Role for RalGDS and a Novel Ras Effector in the Ras-mediated Inhibition of Skeletal Myogenesis* , 1998, The Journal of Biological Chemistry.

[34]  B. Neel,et al.  Protein tyrosine phosphatases in signal transduction. , 1997, Current opinion in cell biology.

[35]  B. Neel,et al.  From Form to Function: Signaling by Protein Tyrosine Phosphatases , 1996, Cell.

[36]  S. Rhodes,et al.  Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1 , 1989, Molecular and cellular biology.

[37]  Y. Nabeshima,et al.  Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts , 1996, The Journal of cell biology.

[38]  Y. Hiroi,et al.  The Rho Family G Proteins Play a Critical Role in Muscle Differentiation , 1998, Molecular and Cellular Biology.

[39]  E. Van Obberghen,et al.  Potential involvement of FRS2 in insulin signaling. , 2000, Endocrinology.

[40]  K. Walsh,et al.  Cardiac Muscle , 2019, Keynes & Aidley's Nerve and Muscle.

[41]  G. Feng.  Shp-2 tyrosine phosphatase: signaling one cell or many. , 1999, Experimental cell research.

[42]  A. Lassar,et al.  Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. , 1994, Current opinion in cell biology.

[43]  B. Olwin,et al.  A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways , 1995, Molecular and cellular biology.

[44]  A. Lassar,et al.  Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase , 1995, Science.

[45]  T. Pawson,et al.  The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. , 1994, The Journal of biological chemistry.

[46]  C. Clegg,et al.  Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor , 1987, The Journal of cell biology.

[47]  B. Neel.  Structure and function of SH2-domain containing tyrosine phosphatases. , 1993, Seminars in cell biology.

[48]  B. Olwin,et al.  Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture , 1988, The Journal of cell biology.

[49]  A. Ullrich,et al.  Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. , 1993, Science.

[50]  D. Kaplan,et al.  SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells , 1993, Molecular and cellular biology.

[51]  N. Jones,et al.  The FGF Receptor–1 Tyrosine Kinase Domain Regulates Myogenesis but Is Not Sufficient to Stimulate Proliferation , 1998, The Journal of cell biology.

[52]  S. Meakin,et al.  The Signaling Adapter FRS-2 Competes with Shc for Binding to the Nerve Growth Factor Receptor TrkA , 1999, The Journal of Biological Chemistry.

[53]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[54]  A. Ullrich,et al.  Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[55]  E. Olson,et al.  bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. , 1994, Genes & development.

[56]  C. Walsh,et al.  Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Imai,et al.  Molecular cloning of a novel protein‐tyrosine phosphatase SH‐PTP3 with sequence similarity to the src‐homology region 2 , 1992, FEBS letters.

[58]  Morag Park,et al.  Molecular Mechanism for the Shp-2 Tyrosine Phosphatase Function in Promoting Growth Factor Stimulation of Erk Activity , 2000, Molecular and Cellular Biology.

[59]  I. Lax,et al.  Binding of Shp2 Tyrosine Phosphatase to FRS2 Is Essential for Fibroblast Growth Factor-Induced PC12 Cell Differentiation , 1998, Molecular and Cellular Biology.

[60]  C. Walsh,et al.  Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. , 1993, The Journal of biological chemistry.

[61]  T. Pawson,et al.  SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. , 1993, Science.

[62]  A. Wolfman,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Mitogen-Activated Protein Kinase Kinase (MEK) Activity Is Required for Inhibition of Skeletal Muscle Differentiation by Insulin-Like Growth Factor 1 or Fibroblast Growth Factor 2* , 2022 .

[63]  L. Thompson,et al.  Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Mikawa,et al.  Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle. , 1996, Development.

[65]  M. Ichihashi,et al.  Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering. , 2000, Molecular biology of the cell.

[66]  M. White,et al.  Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis , 1997, Molecular and cellular biology.

[67]  I. Lax,et al.  FRS2 Proteins Recruit Intracellular Signaling Pathways by Binding to Diverse Targets on Fibroblast Growth Factor and Nerve Growth Factor Receptors , 2000, Molecular and Cellular Biology.

[68]  T. Pawson,et al.  Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp‐2 , 1997, The EMBO journal.

[69]  M. Kasuga,et al.  Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. , 1994, Molecular and cellular biology.

[70]  B. Neel,et al.  The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early xenopus development , 1995, Cell.

[71]  J. Flier,et al.  Divergent Roles of SHP-2 in ERK Activation by Leptin Receptors* , 2001, The Journal of Biological Chemistry.

[72]  M. Goldfarb,et al.  Novel Recognition Motif on Fibroblast Growth Factor Receptor Mediates Direct Association and Activation of SNT Adapter Proteins* , 1998, The Journal of Biological Chemistry.

[73]  Jonathan A. Cooper,et al.  A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase , 1994, Molecular and cellular biology.